THE aim of th e p r es en t s tudy w as to in ves tiga te th e in te rr elation s h ip of th e kin in s ys te m , nitr ic ox ide and eic os an oids in th e
Introduction
Rhe umatoid arth ritis is an autoimmune disease in w hich chronic inflammation of the synovial lining ce lls produc e pain, sw e lling and progre ssive e rosion of the synovial joints. Dumonde & Glynn 1 first desc ribed antige n-induc ed arth ritis (AIA) in rabbits. AIA e volve s as a progressive immunological arthritis , w hich in his topathologic al te rms closely re sembles rheumatoid arthritis in man. The acute phas e of AIA is a typical Arthus re action w hich oc curs in the joint w ith compleme nt activatio n and polymorphonuc lear (PMN) le ukocyte migration . 2 Nitric ox ide (NO) is a ve ry small and ubiquitous molecule synthe size d from L-arg inine by nitric ox ide synthas es (NOS). NO is produc ed in the joint by chondroc yte s, [3] [4] [5] [6] synovioc yte s 6, 7 and oste oblasts. 6 It has bee n invo lve d in inflammatory re actions w ith both p ro and anti-inflammatory prope rtie s. Endogenous re le as e of NO c ould act as anti-inflammatory through the re duction of leukoc yte adhesion, 8, 9 and inhibition of synthe sis of c yclo-ox ygenase produc ts such as prostaglandin E 2 (PGE 2 ), thrombox ane B 2 (Tx B 2 ) and inte rle ukin-6 (IL-6). 10 Endogenous NO has also be en described as a pro-inflammator y molecule show ing inte rac tions w ith c ytokine s [11] [12] [13] and inflammator y produc ts of the cyclo-ox ygenase pathw ay. [14] [15] [16] [17] [18] [19] [20] Studie s have show n that NO inc re as es inte rleukin-1b (IL-1) and e icosanoid produc ts w hich may re sult in the ex acerbation of the inflammatory re spons e. 12, 13 The p artic ipatio n of NO in intraartic ular inflammatory proce ss has bee n fully de sc ribed in arthritic patie nts. 21, 22 NOS inhibitors have bee n w ide ly use d in studie s of NO influenc e in the inflammator y process. The adminis tration of NOS inhibitors in the ex perime ntal arthritis in rats w as follow ed by re duction in the intra-artic ular ac cumulation of leukocyte s, joint e ros ion, and paw sw elling as w ell as his topathologic al abnormalitie s. 23 -27 Inhibition of NO biosynthe sis by L-arginine antago nism re duced PGE 2 produc tion by condroc yte s 3 w ithout effect upon the inc re ase d produc tion of PGE 2 by synoviocyte s stimulate d w ith IL-1. 7 More ove r, e ndogenous re le as e of NO enhanc e s macrophage c yclooxygenase (COX) activ ity and inc re ase s the produc tion of p ro-inflammatory prostaglandins . 13, 28 Se veral studie s sugge st that NO partic ipate s in the inflammatory re spons e and joint destruc tion. Slic es of rabbit artic ular cartilage synthe sized large quantitie s of NO follow ing stimulatio n w ith human re c ombinant IL-1b . Tre atme nt of cartilage fragments w ith NOS inhibitor decre as ed NO synthe sis stimulate d by IL-1b and re store d prote oglycan synthe sis. 29 We pre vious ly verifie d that chronic tre atme nt of arth ritic rabbits w ith L-NAME evoke d re duc tion of the cellular influx and prote in le akage to the artic ular c avity. Additionally the synovial fluid of these animals show ed re duction of PGE 2 , IL1 and NO 2 /NO 3 le ve ls. 30 Chronic adminis tration of NOS inhibitors caus es vasoconstric tion w ith pote ntial re duc tion in c ell migratio n. The contrib ution of this pre ssoric alte ration evoked by chronic tre atment w ith L-NAME to its anti-inflammatory action as w e ll as the p ossible links betw e en NO and othe r me diato rs of inflammatory re ac tion have so far bee n poorly studie d in the artic ular environme nt. Thus, in the pre sent study w e analyz ed the leukoc yte migratio n, prote in leakage , synovium polymorphonuclear ce ll infiltrate and e icosanoids produc tion in the synovial fluid of kne e joints of rabbits w ith AIA tre ate d w ith NOS inhibitor, Enalap ril and the B2 antago nist of Bradykinin HOE 140.
Material and methods

Induction of arthritis
The Animal Ethic s Committe e of COBEA (Brazilian College of Ex perime ntal Animals ) has approve d all ex pe rimental proce dure s pe rforme d on animals in accordanc e w ith procedure s set by UFAW (The Unive rs itie s Federation for Animals We lfare ). Male New Zealand White rabbits w ere se nsitiz ed w ith 5 mg of me thylate d bovine se rum albumin (mBSASigma) in 1 ml Fre und's c omple te adjuvant (Gibc o) and 1 ml of ste rile saline through inje c tions at subc utane ous and muscular site s in the suprasc apular and glute al re gions, re spe ctive ly. Seven days afte r the immuniz atio n the animal w as onc e a w ee k booste d w ith intrade rmic al inje ction of 1 mg/ml of mBSA. The n, cutane ous Arthus re action charac te rize d by central ne c rosis w as obse rve d 24 h late r. Simultane ously, the serum antib ody title s agains t mBSA w ere quantifie d by immunodiffusion. The animals used in the ex perime nt w e re those w ho appropriate ly re sponde d to the se cond cutane ous challenge and have had anti-mBSA title s ove r 1/8. Seven days afte r the third booste r, arthritis w as induc ed in the kne e joint by the inje c tion of 0.5 ml of a ste rile solution of mBSA (2 mg/ml) into the artic ular cavity. The contralate ral joint w as inje cte d w ith saline . Tw e nty four hours afte r intra-artic ular challenge the animal w as anae sthetiz ed w ith a mix ture of x ylazine (5 mg/kg) associate d w ith ke tamine (50 mg/kg) by intramuscular inje ction and afte r that it w as kille d by intrave nous inje c tion of 2.0 ml of KCI 20%.
Treatments
A group of animals w as rando mly tre ate d w ith L-NAME (Sigma), a competitive NOS inhibitor, or its inac tive form D-NAME (Sigma). The dose for both tre atments w as of 20 mg/kg/day mix ed w ith drinking w ate r. Drugs w ere adminis te re d for 2 w ee ks prior to the induc tion of arthritis , and starte d simultane ously w ith the sec ond booste r. Anothe r group of animals w as rando mly tre ate d w ith Enalap ril, an angiote nsin conve rting enzyme (ACE), w hich produce s blood pre ssure decre ase . The tre atme nt w ith Enalap ril starte d simultane ously w ith L-NAME and the dose of the drug w as 0.12 mg/kg/day mix ed w ith drinking w ate r 
Assessment of vascular permeability response with Evans's blue dye
Before mBSA inje c tion to induc e arthritis the animals re c eive d iv. 20 mg/kg of Evans's blue dye in a 2.5% saline solution. The dye combine s w ith the prote ins of the p lasma giving rise to a tagged macromole cule that passe s the endothe lial barrie r only to a ne gligible ex te nt unde r normal conditio ns, but it is de posite d in the tissue s unde r circ umstanc es of inc re ased vas cular permeability. The synovial fluid w as ce ntrifuge d and the optic al density colorime tric ally assessed at 630 nm. The c onc entratio n of dye bound to prote in in the synovial fluid w as e stimate d from a standard graph re c ording the optic al density of serial dilutio n of a know n samp le of Evans's blue in NaCl. Results are ex pre sse d as m g of prote in/ml of synovial fluid.
Synovial membrane histology
Afte r sampling the synovial fluid and opening the artic ular cavity, the synovial membrane w as ex cise d and sec tions w ere staine d w ith he matox ylin and eosin for e valuation of PMN c ell infiltrate unde r light mic rosc opy. The synovium PMN ce ll infiltrate w as quantifie d as absent or rare , mild, or se ve re by an observe r blinde d to the ex p erime ntal groups.
F. A. S. Pa lá cio s et al.
Assay of eicosanoids PGE 2 and LTB 4 levels w e re as saye d in the synovial fluid using comme rc ial kits (Ame rsham, UK) as pre viously de scribe d. 31, 32 The radioim munoassays w ere pe rforme d in polyprop yle ne tube s w ith the re age nts dilute d in phosphate -buffere d saline w ith gelatin and thimerosal. One hundre d microlite rs each of unkno w n sample s, trac ers (I 125 PGE 2 or H 3 LTB 4 ), and rabbit antis e rum to each e icosanoid w ere combine d and inc ubate d ove rnight at 8°C for LTB 4 dete rmination and inc ubate d for 2 hours at 25°C in a w ate r bath for PGE 2 
Results
Leukocyte influx and vascular permeability in the synovial fluid
To inve stigate the c ontrib ution of pre ssoric alte ration to the anti-inflammatory prope rtie s of chronic L-NAME tre atme nt, le ukoc yte influx and prote in leakage to the artic ular c avity w as quantifie d in the synovial fluid c ollec te d from animals tre ate d w ith L-NAME or D-NAME w ith or w ithout Enalap ril. Synovial fluid c ells and vascular permeability w ere measure d 24 hours afte r artic ular challe nge w ith mBSA. Pane l A (Fig. 1) show s the effe ct of L-NAME compare d w ith c ontrol animals in the re duc tion of cellular migratio n to the inflamed are a. The re duc ed migratio n occ urs mainly in the number of polymorphonuc le ar (PMN) leukocyte s, the c entral c ell in the acute p hase of the inflammatory re ac tion, although mononuc lear (MN) ce ll migratio n w as also affe c te d. The simultaneous adminis tratio n of Enalap ril w ith L-NAME partially re store s this parame te r. The ce llular influx to the artic ular cavity observe d in animals tre ate d w ith Enalap ril alone w as similar to that obse rve d in the animals tre ate d w ith L-NAME plus Enalap ril. The synovial fluid of the contro l joint, inje cte d w ith saline ex hibite d only re side nt cells (dotte d line ). Leukoc yte counts in the artic ular c avity of D-NAME tre ate d animals did not diffe r from the leukoc yte count in control anim als, w hich drank only w ate r 30 . The vascular pe rmeability show n in pane l B w as quantifie d by Evans's blue method. Our re sults show ed a signific ant dec re ase in prote in leakage to the artic ular cavity in the synovial fluid c ollec te d from L-NAME tre ate d animals . The kne e joint inje c te d w ith saline show e d low le ve ls of dye bound to prote in. Similar finding s in the prote in leakage to the artic ular cavity w e re observe d in both D-NAME tre ate d anim als and those w hich drank only w ate r. The prote in leakage analyzed in the joint fluid of anim als tre ate d w ith Enalap ril or Enalap ril plus L-NAME did not diffe r from the c ontrol anim als. In all groups evaluate d the synovial me mbrane PMN c ell infiltrate show ed a similar patte rn to the PMN infiltrate observe d in the synovial fluid (data not show n). In a pre vious pap er w e show e d that the synovial membrane of anim als re c eiving mBSA intra-artic ularly had inte nse PMN ce ll infiltrate at 24 hours. Tre atme nt w ith the NOS inhibitor L-NAME, prior to the induc tion of arth ritis , gre atly re duce d the ce ll infiltratio n in the synovial me mbrane 24 hours afte r the induc tion of arth ritis . 
Eicosanoids levels in the synovial fluid
The synovial fluid of animals tre ate d w ith L-NAME, D-NAME, Enalap ril and HOE140 w as c ollec te d, and the eic osanoids PGE 2 and LTB 4 as saye d by radioimmunoas say. The re sults are show n in Figs 3 and 4 re spective ly. The PGE 2 le vel w as signific antly re duce d w ith L-NAME tre atme nt, in ac cordanc e w ith our pre vious re sults. 30 The simultane ous tre atme nt w ith Enalap ril complete ly re ve rte d this inhibitio n. The tre atment of animals w ith HOE 140 drastic ally re duced the level of PGE 2 in all groups e valuate d. It is important to note that the same re sult e ven occ urre d in the group of animals tre ate d only w ith Enalap ril plus HOE 140. The level of LTB 4 show n in Fig. 4 ex hibite d a quite diffe re nt patte rn of alte ratio n. Although re duc ed afte r tre atme nt w ith L-NAME alone or combine d w ith Enalap ril, the level of LTB 4 w as re verte d to that observe d in c ontro l animals w hen the tre atment inc lude d HOE 140. Tre atme nt w ith D-NAME did not affe c t the synovial fluid le vels of e icosanoids
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w hen compare d w ith the re sults obtaine d in animals w hich drank only w ate r. 30 
Discussion
Our pre vious re sults clearly implic ate nitric ox ide in the IL-1 induc ed PGE 2 p roduc tion in the synovial fluid of acute arthritis in rabbits. 30 In this study w e also demonstrate that tre atme nt w ith the NOS inhibitor L-NAME w as as sociate d w ith a re duction in some signs of ac ute artic ular inflammation in rabbits such as vascular pe rmeability and synovial membrane PMN ce ll infiltrate . In the ac ute phas e of AIA w e notic ed a re duction in the numbe r of leukocyte s c oming to the inflamed are a. This finding is consiste nt w ith the study of Belenky e t a l., 33 w ho found that NOS inhibitors atte nuate d chemotax is of unstimulate d and prime d PMN leukoc yte s. Kaplan e t a l., 34 using pe ripheral human ne utrophils inc ubate d w ith the NOS inhibitor, LNMA, de mons trate d a re duction of leukocyte che motax is to FMLP. This inhibitio n could be ove rc ome if L-arginine or dibutyryl cGMP w e re adde d togethe r w ith the LNMA. These studie s point out the importanc e of NO in the dire c tion of ce ll moveme nt. Our re sults cle arly show that unde r inflammatory challe nge the migrator y re sponse of PMN ce lls and the synovium PMN c ell infiltrate w e re re duce d in animals tre ate d w ith L-NAME. This sugge sts that the endothelial lining of ve sse ls w ithin the rabbit synovium may be an unusual microvasc ular ne tw ork. We hypothe sized that chronic tre atment w ith an NOS inhibitor promote s vasc ular pre ssoric alte ratio n that could be account for its anti-inflammatory action. The simultane ous tre atme nt of the se animals w ith Enalapril, an ACE inhibitor, re store d the ce llular influx , prote in le akage and eicosanoids produc tion almost to the normal range observe d in contro l arth ritic joints . BK induc e s inc re ase in the blood flow of the rabbit synovium via activatio n of B2 re c eptors. 35 Then, w e also analyz ed the partic ipation of the kinin syste m through co-adminis tration of a B2 antagon ist of BK HOE 140 to the animals , before and during the arthritis de ve lopme nt. This tre atme nt promote d re markable re duction of c ellular influx , prote in leakage and PGE 2 le ve l in the synovial fluid. It is w orth noting that conc omitant adminis tration of HOE 140 comple te ly abolished the inc re ase of the inflammatory parame te rs promoted by Enalap ril to L-NAME tre ate d animals .
NO appears to be gene rate d by the vasc ular endothelial ce lls via constitutive NO synthas e stimulate d by inflammatory mediators like histamine , 5 hydrox ytryptamine and Bradykinin or by the inducible enzyme carrie d to the inflammator y site by PMN ce lls. 36 The magnitude in the re duc tion of the inflammator y parame te rs observe d w ith HOE 140 tre atment suggests that NO gene ratio n in ex perime ntal arth ritic joints follow s BK stimulation of B2 re c eptors. The re sults obtaine d in all animals tre ate d w ith the B2 antago nist of Bradykinin irre sp ective of othe r tre atme nts w e re similar to the value s observe d in anim als tre ate d only w ith L-NAME and inc luded the level of NO 2 /NO 3 (data not show n). The only ex c eption w as in the le ve l of LTB 4 me as ure d in the ex pe rimental joints of HOE tre ate d animals , w hich re sult is compare d w ith those obtaine d w ithout HOE tre atment. This finding suggests a possible inhibitor y action of kinin syste m produc ts in the lipoox yge nase pathw ay. LTB 4 w ould be c onside re d a p ote nt chemotac tic in the ac ute phase of inflammatory re spons e. 37 We have re c ently found that LTB 4 animals at 4 hours of arthritis (LTB) 4 4th h= 2.48±0.16 ng/ml; LTB 4 24th h = 0.95±0.14 ng/ml). 38 The re duce d levels of LTB 4 in anim als tre ate d only w ith Enalap ril c orroborate pre vious re sults in arth ritic patie nts tre ate d for arte rial hyperte nsion w ith ACE inhibitors . 39, 40 The re duce d levels of LTB 4 and the impaire d migration of le ukocyte s to the artic ular cavity in L-NAME tre ate d animals suggest that another me diato r apart, LTB 4 possibly can be invo lve d in the ce ll attrac tion to the artic ular cavity in this phase of AIA development.
The inte rac tions be tw een PGE 2 IL-1 and NO synthesis have been re late d in many studie s. 3, 4, 5, 12, 20, 41 These studie s show that the e ndoge nous re le as e of NO e nhanc es COX ac tivity w ith furthe r inc re ase of PGE 2 . High c once ntrations of PGE 2 inhibite d NOS ex pre ssion and decre ase d NO synthe sis.
14 Whe n NO production w as blocked by NOS inhibitors both NO and PGE 2 simultane ously de cre ase d. 12, [16] [17] [18] [19] 25, 28, 42 NOS inhibitors also block cytokine induc ed re leas e of PGE. 11, 13 In the se in v itro ex perime nts NO see ms to be one of the most important signals in the activatio n of c yclo-ox ygenas e to produc e PGE 2 . We pre viously found that inhibitio n of NO produc tion w ith L-arg inine antago nist L-NAME signific antly re duced IL-1b and PGE 2 le ve ls in the synovial fluid, w ith simultane ous re duc tion of total NO 2 /NO 3 and suppre ssion of AIA. 30 In this study w e verifie d that tre atment w ith an ACE inhibitor, Enalap ril, w as effic ie nt in the re version of inflammatory parame te rs in the synovial fluid induc e d by NOS inhibition. This effe ct may not be in conse que nce of arte rial pre ssure normaliz ation but due to Bradykinin accumulation at the site of injury and w as complete ly blocked by adminis tration of BK antagon ist HOE 140.
Toge the r our re sults show that the pre ssoric me chanis m ac ting in chronic adminis tratio n of L-NAME did not ac count for all anti-inflammatory propertie s of NOS inhibitors in the developme nt of AIA in rabbits . Additio nally w e demons trate the partic ipatio n of Bradykinin in the acute phase of antige n-induc e d arthritis in rabbits as w ell as the inte rre lations hip of the kinin syste m w ith NO and eic osanoids produc tion in the arthritic joint.
